In this white paper, Aia Malik, Commercial Development Manager, Healthcare, and Gilda Gasparini, senior Chemical Engineer, discuss the journey behind Lucideon’s proprietary iCRT-deter technology.

iCRT is a novel series of carriers based on inorganic materials, designed to enhance the delivery of APIs by providing protection of actives and improved stability.

iCRT-deter, one of the technologies in this platform, applies all these features, including controlled release to provide protection of high dose or addictive drug formulations, including opioids.

This paper will review the escalating prescription abuse problem, Abuse Deterrent Formulation (ADF) drivers and the key factors that shaped the design of iCRT-deter.

Download White Paper